Toggle Side Panel
Close search

Morphogen-IX Gets $23.2M to Develop New PAH Therapy

  • Research & Development

    Morphogen-IX Gets $23.2M to Develop New PAH Therapy

    Posted by Community Member on January 9, 2019 at 2:03 pm

    Morphogen-IX has raised $23.2 million to advance development of MGX292, its lead drug candidate for treatment of pulmonary arterial hypertension. Click here to learn more.

    What do you think about this news?

    replied 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.

Start of Discussion
0 of 0 replies June 2018
Now

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .